Global Biopharmaceutical Company
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Our company: Industry leadership in BioPharma
Learn more about Bristol Myers Squibb, a global biopharma company dedicated to discover, develop and deliver innovative medicines to patients with serious diseases.
About us
Learn about global biopharmaceutical innovator Bristol Myers Squibb, helping millions to fight cancer, cardiovascular disease, HIV/AIDS, and more.
BMS Careers
From the scientists behind the microscope to the analysts behind the data, everyone at BMS is working to make an impact. And while our work transforms the lives of patients, it also
Bristol Myers Squibb | LinkedIn
At Bristol Myers Squibb, we work every day to transform patients'' lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you''ll experience.
Bristol Myers Squibb
In October, BMS announced it would acquire cardiology company MyoKardia for $13.1 billion ($225 per share) gaining control of mavacamten, a cardiovascular drug for obstructive
Building automation
Systems linked to a BMS typically represent 40% of a building''s energy usage; if lighting is included, this number approaches to 70%. BMS systems are a critical component to managing
Investor relations
Find information and tools for investors, stockholders and financial analysts, including share and dividend information, acquisition-related information, latest news and corporate reporting.
Home | Medical Information
Use our Study Finder to help identify new or currently recruiting Bristol Myers Squibb sponsored studies that are being conducted. Submit your question to our team of medical professionals.